Published by Michele Maatouk on 9th October 2025
(Sharecast News) - Denmark's Novo Nordisk said on Thursday that it has agreed to buy Akero Therapeutics - a clinical-stage company developing treatments for patients with serious metabolic diseases - for up to $5.2bn.
URL: http://www.digitallook.com/dl/news/story/35412500/...